Focused ultrasound for alcohol use disorder could eventually offer a noninvasive way to influence brain circuits associated with reward and reinforcement. A new preclinical study reports that precisely targeted ultrasound reduced alcohol consumption in mice, providing early evidence for an image-guided approach to deep-brain neuromodulation.
The findings remain preliminary. Still, they address a central challenge in interventional psychiatry: reaching small structures deep within the brain without surgery or damage to surrounding tissue.
Why Current Alcohol Treatments Leave Room For New Approaches
Approved medications for alcohol use disorder include naltrexone, acamprosate, and disulfiram. These treatments can help some patients reduce drinking or maintain abstinence, particularly when combined with behavioral support.
However, treatment response varies, relapse remains common, and sustained participation can be difficult. Researchers are therefore investigating whether direct modulation of reward circuitry could complement existing pharmacological and psychosocial care.
Deep brain stimulation can reach subcortical targets, but it requires implanted electrodes and neurosurgery. Transcranial magnetic stimulation is noninvasive, although its ability to precisely reach small, deeply situated nuclei is limited.
Focused Ultrasound For Alcohol Use Disorder Introduces A Deeper Target
Researchers at the University of South Florida developed an ultrasound-guided low-intensity focused ultrasound platform called USg-LIFU. The system was designed to deliver acoustic energy to a defined deep-brain location without creating a lesion.
The team targeted the ventral tegmental area, or VTA. This structure contains dopamine-producing neurons that communicate with regions involved in motivation, reward valuation, and reinforcement learning. Because alcohol can engage these pathways, the investigators hypothesized that repeated VTA modulation might alter voluntary drinking.
Personalized Acoustic Maps Address A Targeting Problem
Ultrasound does not travel through every skull and brain in exactly the same way. Differences in tissue thickness, sound speed, and acoustic attenuation can weaken the beam or move its focal point away from the intended target.
To address this problem, the platform used ultrasound tomography to construct subject-specific maps of acoustic velocity. Researchers incorporated those measurements into finite element simulations that predicted how the beam would travel through each animal’s head.
A motorized positioning system then adjusted the alignment of the animal and transducer so the predicted focus converged on the VTA. Ex vivo experiments used high-intensity ultrasound to produce a visible thermal mark, confirming that the system could direct energy toward the predefined intracranial location. The therapeutic animal experiments used low-intensity, non-ablative stimulation.
Alcohol Intake Declined Across Six Treatment Sessions
The in vivo experiment included 15 selectively bred, high-alcohol-preferring mice. Ten received six VTA-targeted LIFU sessions on alternating days, while five received sham procedures.
Across the treatment period, mean alcohol consumption decreased by approximately 51% in the LIFU group. Sham-treated mice maintained or increased their alcohol preference.
The average change in alcohol consumption was a 2.35-gram decrease among treated mice, compared with a 2.05-gram increase among sham controls. Water consumption moved in the opposite direction, increasing in treated animals and declining in controls.
Blood alcohol concentration in the treated group fell from an average of 33.97 mg/dL before treatment to 26.41 mg/dL during treatment and 20.86 mg/dL after the sixth session. One treated mouse showed little or no behavioral response, highlighting meaningful variability within the small sample.
Mechanical Neuromodulation May Alter Reward Processing
Low-intensity focused ultrasound delivers pressure waves rather than magnetic or electrical stimulation. Although its complete biological mechanism remains under investigation, acoustic energy may influence neuronal membranes and mechanosensitive ion channels, temporarily changing cellular excitability.
In this study, the behavioral pattern was consistent with modulation of mesolimbic reward circuitry. However, the researchers did not perform molecular or post-treatment histological analyses, so the experiment cannot establish exactly how VTA activity changed.
A Technical And Behavioral Proof Of Concept
The study combines two important demonstrations: individualized acoustic targeting and measurable alcohol-related behavioral change. The full imaging, modeling, alignment, and stimulation workflow reportedly took about five minutes per animal, suggesting potential efficiency for repeated preclinical experiments.
Important limitations remain. The study used only 15 mice, the groups were unequal in size, and the computational model was two-dimensional. Translation to humans will require three-dimensional modeling, larger studies, detailed safety testing, biological confirmation of target engagement, and controlled clinical trials.
For now, focused ultrasound for alcohol use disorder should be viewed as an emerging research direction rather than a treatment option. Its promise lies in the possibility of reaching deep reward circuits with greater precision while avoiding implanted hardware, a combination that could broaden the future neuromodulation toolkit.
Citations
Mondal S, Yang H, Gulick D, et al. “Image-Guided Low-Intensity Focused Ultrasound Neuromodulation: Acoustic Targeting Optimization and Functional Validation in a Reward Circuit Model.” Brain Stimulation. 2026;19:103190. https://doi.org/10.1016/j.brs.2026.103190
McPheeters M, O’Connor EA, Riley S, et al. “Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.” JAMA. 2023;330:1653–1665. https://doi.org/10.1001/jama.2023.19761
Explore more at https://www.interventionalpsychiatry.org/
